Multi-modality Noninvasive Biosensor for Health Behaviors

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Kenan Laboratories at the University of North Carolina at Chapel Hill, Chapel Hill, NC
Health Behaviors+1 More
Multi-modality Noninvasive Biosensor - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to investigate the safe wearability and basic functions of the multi-modality sensors fabricated in the PI lab.

Eligible Conditions

  • Health Behaviors
  • Healthy Subjects (HS)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: Through study completion, an average of 15 minutes.

Hour 48
Mean Comfort Level of Wearable Sensors
Safety assessed up to 10 minutes after device application.
Mean Safety Scores
Through study completion, an average of 15 minutes.
Mean Agreement Over Time of Physiological Parameters between Newly-Fabricated Wearable Sensors and Approved Devices.

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Participants wearing biosensor
1 of 1
Experimental Treatment

12 Total Participants · 1 Treatment Group

Primary Treatment: Multi-modality Noninvasive Biosensor · No Placebo Group · N/A

Participants wearing biosensorExperimental Group · 3 Interventions: Portable Blood Pressure Monitor, Multi-modality Noninvasive Biosensor, Oximeter · Intervention Types: Device, Device, Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oximeter
2018
N/A
~20

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 15 minutes.
Closest Location: Kenan Laboratories at the University of North Carolina at Chapel Hill · Chapel Hill, NC
N/AFirst Recorded Clinical Trial
1 TrialsResearching Health Behaviors
0 CompletedClinical Trials

Who is running the clinical trial?

North Carolina Translational and Clinical Sciences InstituteOTHER
52 Previous Clinical Trials
4,498 Total Patients Enrolled
University of North Carolina, Chapel HillLead Sponsor
1,347 Previous Clinical Trials
3,908,576 Total Patients Enrolled
5 Trials studying Health Behaviors
302,165 Patients Enrolled for Health Behaviors
Wubin Bai, PhDPrincipal InvestigatorAssistant Professor of Applied Physical Sciences

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.